logo
Sign in

PEN Stock Price, Chart, Stats & News

Penumbra, Inc.
Save
12.44B
Market cap
82.60x
Current P/E
62.89x
Forward P/E

PEN chart

1M
3M
1Y
5Y
Loading chart...

Fundamentals

Gross margin
67.14%
Operating margin
13.48%
Pretax margin
14.61%
Net margin
12.66%
Effective tax rate
13.38%
ROA
9.73%
ROE
13.43%
D/E
0.15x
Interest coverage ratio
193.31x

PEN valuation

P/E
82.60x
P/S
9.37x
P/B
9.20x
P/CF
55.03x
P/FCF
75.17x
P/OCF
55.03x
PEG
9.50x
EV multiple
58.67x

About

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands.

Similar securities

Based on sector and market capitalization

Report issue